| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| raloxifene | estrogen receptor alpha | small molecule | NA | drugbank , DGIDB | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved,investigational | agonist,antagonist |
| raloxifene | estrogen receptor alpha | small molecule | NA | drugbank , DGIDB | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved,investigational | agonist |
| raloxifene | estrogen receptor | NA | Successful target | TTD , DGIDB | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | agonist,antagonist |
| raloxifene | estrogen receptor | NA | Successful target | TTD , DGIDB | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | unknown |
| raloxifene | estrogen receptor beta | small molecule | NA | drugbank , DGIDB | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.37 | approved,investigational | agonist,antagonist |
| raloxifene | estrogen receptor beta | small molecule | NA | drugbank , DGIDB | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.37 | approved,investigational | agonist |
| raloxifene | serpin b9 | small molecule | NA | drugbank | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| raloxifene | trefoil factor 1 | small molecule | NA | drugbank | Osteopenia[MeSHID:D001851] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Osteoporosis Postmenopausal[MeSHID:D015663] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| click here to return to the previous page | ||||||||